Alnylam Pharmaceuticals, Inc.
Compositions and methods for inhibition of expression of protein C (PROC) genes
Last updated:
Abstract:
The invention relates to double-stranded ribonucleic acid (dsRNA) targeting a PROC gene, and methods of using the dsRNA to inhibit expression of PROC.
Status:
Grant
Type:
Utility
Filling date:
11 Nov 2019
Issue date:
14 Sep 2021